Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.
Also called NCT07740330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- Clinique Saint-Luc
- Registry
-
NCT07740330 -
2026-526581-24-01
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07740330. Randomized; quadruple masking; primary purpose prevention. Start 2026-10 (anticipated); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery
- Acronym
- TRANSCAB
- Condition
- Coronary Artery Disease
- Condition
- Perioperative Bleeding
- Intervention (Drug)
- Oral tranexamic acid
- Intervention (Drug)
- Exacyl®
- Intervention (Drug)
- Intravenous placebo
- Lead sponsor
- Clinique Saint-Luc
Record details
- Record id
cardio:ct-nct07740330- Content hash
2519c4c29e4927575b65025ce948a6b190fef58a89d805acbff79738774b055f